INSANE: Athira - The Real Truth

Why Athira Pharma Stock Is Plunging

Athira Pharma Inc (NASDAQ: ATHA) shares are falling Wednesday after the company announced topline results from its exploratory ACT-AD Phase 2 study of fosgonimeton in patients with mild-to-moderate Alzheimer's disease.

Benzinga · Jun 22, 2022

Washington biotech firm and activist investor feud over control of Alzheimer's research

These are delicate times for Athira Pharma, a Bothell, Washington-based biotech firm in clinical trials for treatment for Alzheimer's and Parkinson's dementia.

Tribune News Service · May 12, 2022